In this issue:
Larotrectinib efficacious for TRK fusion-positive solid tumours
CheckMate 77T: Perioperative nivolumab prolongs EFS in NSCLC
Subcutaneous atezolizumab preferred by patients with NSCLC
Triplet neoadjuvant chemotherapy boosts survival in oesophageal cancer
Benefit with adjuvant immunotherapy in MIBC
Neoadjuvant therapy in HER2 (3+) vs HER2 (2+)/ISH+ early-stage breast cancer
AMEERA-5 trial of front-line SERD + palbociclib for ER+ breast cancer terminated
Methylphenidate does not relieve cancer-related fatigue
Chemotherapy backbone options for definitive chemoradiotherapy of inoperable ESCC
IMpassion132: no survival benefit to immunotherapy in early relapsing TNBC
Please login below to download this issue (PDF)